Differentiating subconjunctival lesions can be challenging even among experienced clinicians. Discover how to diagnose and manage conjunctival melanoma, lymphoma, myxoma, neuroma, and amyloidosis, and benign reactive lymphoid hyperplasia.
Merkel cell carcinoma is a rare, aggressive cutaneous neuroendocrine carcinoma. Learn about the diagnostic workup, prognostic markers, current treatments, and emerging targets.
Uveal melanoma is the most common intraocular malignancy in adults, representing a rare but aggressive subtype. Get up to date with the latest options for treating patients with metastatic disease.
Compared with the general population, childhood cancer survivors have a twofold increased risk for melanoma, with substantially worse survival for those who develop invasive melanoma.
Therapies designed to penetrate the blood-brain barrier and target key drivers like EGFR, ALK, HER2, and BRAF have revolutionized treatment of brain metastases from non-small-cell lung cancer, breast cancer, and melanoma.
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.
In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.
Please note, this webinar is not intended for healthcare professionals based in the US and UK.
The amelanotic variant of conjunctival malignant melanoma is extremely rare and can be difficult to diagnose. Clinicians must be vigilant when changes in the conjunctiva and eyelids are noticed.
Intralesional treatment with the oncolytic virus talimogene laherparepvec led to a complete local response in a patient with oral mucosal melanoma who was ineligible for other anticancer therapies.
A case of clear cell sarcoma of soft tissue misdiagnosed as malignant melanoma underscores the need for an integrated diagnostic approach involving clinical, histopathological, and radiological evaluations.
Non-melanoma skin cancers (NMSCs), particularly basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC), are the most common malignancies in the Caucasian population. While localized disease has a high cure rate, advanced cases …
Cutaneous squamous cell carcinoma (cSCC) is the second most common nonmelanoma skin cancer (NMSC) and is predominantly found in the head and neck region. With an annual increase in NMSC diagnoses, cSCC presents significant diagnostic and …
Tumor-infiltrating lymphocyte (TIL) therapy is a type of personalized immunotherapy that harnesses the antitumor activity of endogenous immune cells. While TIL therapy has been in clinical investigation since the 1980s and shown promising signs of …
Nonmelanoma skin cancer (NMSC), including basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC), is the most common form of skin cancer. cSCC can usually be cured if detected and treated early. Prompt treatment is essential, as …
An expert-led symposium exploring the most pertinent issues in cardio-oncology, with a focus on the new ESC guidelines. Highlights include preventative approaches in cardio-oncology, toxicity risk-stratification strategies, the clinical management of myocarditis as an adverse effect of immune checkpoint inhibitor-treatments, and the utility of biomarkers in long-term follow-up of cardiovascular disease risk in cancer patients.
Take on interactive case studies with a focus on hematology. Each case has been prepared by renowned experts in the field and features knowledge-check questions with answers to help keep you and your practice up to date.
Vitiligo, a prevalent depigmenting disorder, is characterized by the focal loss of melanocytes within the epidermis, leading to the formation of characteristic white patches [ 1 ]. The progression of vitiligo is influenced by a complex interplay of …
Cellular heterogeneity presents a significant challenge to cancer treatment. Antibody therapies targeting individual tumor-associated antigens can be extremely effective but are not suited for all patients and often fail against tumors with …
Locally advanced squamous cell skin cancer (LA-sqCSC) affects older patients who initially decline medical assistance and patients after multiple surgical interventions for recurrent tumors. Radical radiotherapy (RT) often becomes difficult to …
Melanoma accounts for 1.7% of all global cancer diagnoses [ 1 ], with Australia and New Zealand having some of the highest incidence rates (age-standardized rate of 35.8 per 100,000 persons) [ 2 ]. Prognosis for cutaneous melanoma heavily depends …
